Inventor · disambiguated record
Emmanuelle Vigne
Also filed as: VIGNE EMMANUELLE
15 granted patents·10 pending applications·536 citations·filing 1994–2025
95Inventor score
Top patents by PatentIndex Score
25 records- 0195US7033826B2Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenovirusesAVENTIS PHARMA SA·Filed 2002·Granted Apr 25, 2006·62 cites·10 claims
- 0293US6127175ACells for the production of recombinant adenovirusesRHONE POULENC RORER SA·Filed 1996·Granted Oct 3, 2000·182 cites·33 claims
- 0390US6911199B2Targeted adenovirus vectors for delivery of heterologous genesAVENTIS PHARMA SA·Filed 2001·Granted Jun 28, 2005·38 cites·46 claims
- 0482US5866551ARecombinant adero viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemiasRHONE POULENC RORER SA·Filed 1994·Granted Feb 2, 1999·40 cites·11 claims
- 0578US6387670B1Method for producing recombinant virusAVENTIS PHARMA SA·Filed 1997·Granted May 14, 2002·38 cites·27 claims
- 0676US6033885AIntegrative recombinant adenoviruses, preparation thereof and therapeutical uses thereofRHONE POULENC RORER SA·Filed 1995·Granted Mar 7, 2000·38 cites·31 claims
- 0772US6410298B1Adenovirus vectors and method for reducing homologous recombination phenomenaAVENTIS PHARMA SA·Filed 1998·Granted Jun 25, 2002·28 cites·19 claims
- 0869US6294377B1Adenoviral vectors of canine originRHONE POULENC RORER SA·Filed 1994·Granted Sep 25, 2001·23 cites·6 claims
- 0966US6261807B1Method for preparing a recombinant adenovirus genomeRHONE POULENC RORER SA·Filed 1996·Granted Jul 17, 2001·22 cites·22 claims
- 1065US2025215102A1Cd28/ox40 bispecific antibodiesSANOFI SA·Filed 2024·Application pending·0 cites
- 1164US12195546B2CD28/OX40 bispecific antibodiesSANOFI SA·Filed 2023·Granted Jan 14, 2025·0 cites·26 claims
- 1264US6245330B1Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF)AVENTIS PHARMA SA·Filed 1995·Granted Jun 12, 2001·28 cites·24 claims
- 1362US2024262923A1Anti-pd-1×4-1bb binding proteinsGENZYME CORP·Filed 2023·Application pending·0 cites
- 1457US6420170B1Recombinant adenoviruses containing an inducible promoter controlling a gene of viral originAVENTIS PHARMA SA·Filed 1996·Granted Jul 16, 2002·10 cites·32 claims
- 1555US6685934B1Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF)AVENTIS PHARMA SA·Filed 1995·Granted Feb 3, 2004·12 cites·21 claims
- 1655US2005069523A1Recombinant adenoviruses encoding glial cell neurotrophic factor (GDNF)RHONE POULENC RORER SA·Filed 2003·Application pending·0 cites
- 1753US2003022356A1Method for producing recombinant virusFiled 2002·Application pending·0 cites
- 1852US6200798B1Defective recombinant adenoviruses with inactivated IVa2 geneRHONE POULENC RORER SA·Filed 1995·Granted Mar 13, 2001·8 cites·26 claims
- 1951USRE38556ERecombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemiasAVENTIS PHARMA SA·Filed 1994·Granted Jul 13, 2004·7 cites·17 claims
- 2049US2006002893A1Targeted adenovirus vectors for delivery of heterologous genesVIGNE EMMANUELLE·Filed 2005·Application pending·0 cites
- 2148US2004224409A1Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)Filed 2003·Application pending·0 cites
- 2243US2003096787A1Defective adenovirus vectors and use thereof in gene therapyFiled 2002·Application pending·0 cites
- 2341US2025340642A1Anti-cd28 antibodiesSANOFI SA·Filed 2025·Application pending·0 cites
- 2428US2002031493A1Recombinant adenoviruses coding for glial-derived cell neurotrophic factor (gdnf)RHONE POULENC RORER SA·Filed 1997·Application pending·0 cites
- 2522US2002028212A1Recombinant viruses coding for a glutamate decarboxylase (gad) activityFiled 1995·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Emmanuelle Vigne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →